ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Bietti crystalline dystrophy in Türkiye: A genetic crossroads between Asia and Europe.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo analyse the genotype and phenotype characteristics of Turkish patients clinically diagnosed with Bietti Crystalline Dystrophy (BCD).
methodsThe clinical findings and the genetic testing results of patients diagnosed with BCD were analyzed retrospectively.
resultsThirty-two patients from 26 families were included in the study. Parental consanguinity was reported in 14 patients (43.7%). All patients carried biallelic pathogenic or likely pathogenic variants in CYP4V2. In total, 12 different CYP4V2 variants were identified, three of which were novel: c.802-1G > A, c.802–2 A > C, and c.464 A > C (p.His155Pro). The most common variants were c.1198 C > T (p.Arg400Cys), with an allelic frequency of 23.4% (15/64), and c.802–8_810del17insGC, with an allelic frequency of 18.8% (12/64). Clinical features, including age of onset, visual acuity, disease stage, and optical coherence tomography (OCT) findings, did not differ significantly between genotype groups (p > 0.05). Interocular asymmetry in visual acuity and OCT parameters, as well as variability of clinical findings between siblings and among unrelated patients carrying the same CYP4V2 variants, were observed in the cohort.
conclusionThis study, one of the largest European cohorts and the first comprehensive series from Türkiye, broadens the mutational spectrum of CYP4V2 with three novel variants and highlights the marked phenotypic variability of BCD, even within families. The unexpectedly high frequency of c.802–8_810del17insGC in the Turkish population, previously reported mainly in East Asia, provides new insights into the geographic distribution of this variant.
Indexed as
Identifiers
42008154What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.